HEMOSATE ULTRA HS0125 SOLUTION

Šalis: Kanada

kalba: anglų

Šaltinis: Health Canada

Nusipirk tai dabar

Prekės savybės Prekės savybės (SPC)
15-01-2021

Veiklioji medžiaga:

CITRIC ACID; SODIUM ACETATE; DEXTROSE; MAGNESIUM CHLORIDE; CALCIUM CHLORIDE; SODIUM CHLORIDE

Prieinama:

CHIEF MEDICAL SUPPLIES LTD

ATC kodas:

B05ZA

INN (Tarptautinis Pavadinimas):

HEMODIALYTICS, CONCENTRATES

Dozė:

6.91G; 1.11G; 49.5G; 2.14G; 6.24G; 263G

Vaisto forma:

SOLUTION

Sudėtis:

CITRIC ACID 6.91G; SODIUM ACETATE 1.11G; DEXTROSE 49.5G; MAGNESIUM CHLORIDE 2.14G; CALCIUM CHLORIDE 6.24G; SODIUM CHLORIDE 263G

Vartojimo būdas:

HAEMODIALYSIS

Vienetai pakuotėje:

100

Recepto tipas:

Ethical

Gydymo sritis:

HEMODIALYSIS SOLUTION

Produkto santrauka:

Active ingredient group (AIG) number: 0652910001; AHFS:

Autorizacija statusas:

APPROVED

Leidimo data:

2021-01-15

Prekės savybės

                                Page 1 of 7
PRODUCT MONOGRAPH
HEMOSATE ULTRA HS0125
Haemodialysis Solution, BP
Sodium Chloride
263 g / L
Potassium Chloride
0 g / L
Calcium Chloride
6.24 g / L
Magnesium Chloride
2.14 g / L
Citric Acid
6.91 g / L
Sodium Acetate
1.11 g / L
Glucose Monohydrate
49.5 g / L
CHIEF MEDICAL SUPPLIES LTD.
DATE OF REVISION:
411-19
th
Street S.E.
January 15, 2021
Calgary Alberta T2E 6J7
CONTROL NO.: 242808
Page 2 of 7
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION………………………...
3
SUMMARY PRODUCT
INFORMATION……………………………………...
3
INDICATIONS AND CLINICAL
USE…………………………………………
3
CONTRAINDICATIONS……………………………………………………….
3
WARNINGS AND
PRECAUTIONS……………………………………………
4
ADVERSE
REACTIONS………………………………………………………..
4
DRUG
INTERACTIONS………………………………………………………...
4
DOSAGE AND
ADMINISTRATION…………………………………………..
4
OVERDOSAGE………………………………………………………………….
5
ACTIONS AND CLINCAL PHARMACOLOGY………………………………
6
STORAGE AND
STABILITY…………………………………………………...
6
DOSAGE FORMS, COMPOSITION AND PACKAGING……………………..
6
REFERENCES……………………………………………………………………
6
MORE
INFORMATION…………………………………………………………
6
Page 3 of 7
HEMOSATE ULTRA HS0125
Haemodialysis Solution, BP
PART I: HEALTH PROFESSIONAL INFORMATION
SUMMARY PRODUCT INFORMATION
ROUTE OF ADMINISTRATION
DOSAGE FORM / STRENGTH
CLINICALLY RELEVANT NON-
MEDICINAL INGREDIENTS
Hemodialysis
Concentrated solution
Sodium Chloride 263 g / L
Potassium Chloride
0 g / L
Calcium Chloride 6.24 g / L
Magnesium Chloride 2.14 g / L
Citric Acid 6.91 g / L
Sodium Acetate 1.11 g / L
Glucose Monohydrate 49.5 g / L
None
INDICATIONS AND CLINICAL USE
Hemosate Ul
                                
                                Perskaitykite visą dokumentą
                                
                            

Peržiūrėti dokumentų istoriją